The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Automotive
  • Financial
  • Music
  • Entertainment

Beneficience.com Legacy PR Announces Dr. Burd Renowned Diabetes Scientist, Biochemist-entrepreneur and Dexcom Founder, client
The PennZone/10216335

Trending...
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 119
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • ToneWell Launches AI Wellness Platform with 30-Second Voice-Based Performance Readiness Scan™
Beneficience Com Announces Dr John Burd, Renowned Dr John Burd Lysulin© Dr Burd Wonder Spray Skin Rescue 8oz Skin Rescue Lysulin© Products Beneficience.com Legacy PR
Dr. Burd is a renowned diabetes scientist and biochemist and Founder of Dexcom, the worldwide leader in Continuous Glucose Monitoring (CGM) systems. Get to know him and what good he is doing in the world, and for whom his life work benefits.

SAN DIEGO - PennZone -- About John Burd, PhD:

Dr. Burd is Founder & CEO of Lysulin, Inc and Wonder Spray, llc.  In 2017 Dr. Burd founded Lysulin, Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes.   The first patented product, Lysulin®, was launched in January 2018 and is showing remarkable results in clinical studies in lowering HbA1c and glycated proteins, the cause of disease complications.  In 2019 Dr. Burd founded Wonder Spray, llc to provide relief for a variety of ailments and skincare problems using a natural and safe chemical that is used by white blood cells to kill all pathogens.

Dr. Burd was previously President & CEO of DexCom, where he directed the company's work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes.  In April 2005, DexCom completed a successful IPO, valuing the company at over $500 million.  In 2020 DexCom had a market cap of over $40 billion.  From 1999 to 2004 Dr. Burd was a General Partner of Windamere Venture Partners.

Before founding DexCom, Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, which developed and marketed the Duetâ Diabetes Control System to healthcare professionals and the In ChargeÔ Diabetes Control System to the diabetes self-testing market.  LXN was sold to Johnson and Johnson in 2000.

More on The PennZone
  • Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
  • BET and Soul Train Awards - GONE! - Introducing The World Hip Hop Awards
  • Australian Aboriginal Cultural Immersions and First Nations Workshops
  • Uk Financial Ltd Featured In New York Business Now — 2019 Gold-Backed Bitcoin Prediction Now Becomes SEC Security Token Filing
  • MROVI Trailer Parts Launches Its Own Tire Brand: Introducing MROVI Tires and the New Didgori Trail Tread

Previously, Dr. Burd held executive positions at QUIDEL Corporation, where he directed the development of enzyme immunoassay products for the clinical lab, physician's office and OTC markets. Prior to joining QUIDEL, Dr. Burd was Executive Vice President and COO for MAST Immunosystems, Inc. where he was responsible for the company's operations, including research and development, marketing, sales and finance.  MAST Immunosystems was purchased by Hitachi Chemical in 1997.  Previously, Dr. Burd was involved in other medical product research and development at Miles Laboratories, Inc. (now Bayer Corporation).

Dr. Burd has authored and co-authored over 45 articles and his work in the medical and biotechnology field has led to the filing and ownership of forty patents and the development of many innovative medical products.  He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.  In 2010 Dr. Burd was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.

Disclaimer: Dr. Burd's published product statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

JOHN F. BURD, Ph.D.

Founder & CEO Lysulin, Inc and Wonder Spray, llc.

More on The PennZone
  • AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders
  • Q4 2025 Outlook: JGCMGS Unveils High-Frequency Infrastructure for Italian and Global Markets
  • NEW SEASON OF "The Really Real Estate" APPROVED
  • UK Financial Ltd Announces Full Ecosystem To Erc-3643 "SEC-Ready" Tokens For All UK Financial Ltd Tokenized Projects

4930 Bradshaw Court, San Diego, CA  92130
Phone: 619-992-2873

Website: Promotes Healthy Insulin Function and helps maintain healthy A1c (lysulin.com)

Learn more about Dr. Burd's products below...

Insulin resistance: https://www.youtube.com/watch?v=rdiHqff3EY8



Lysulin video:  https://www.youtube.com/watch?v=PK3CkMty6RE



Running A1c test: https://tinyurl.com/y379jbla

Wonder Spray:
https://www.youtube.com/channel/UCYFv1jgn3LmADcZklzLbMHA/videos

Follow Burd's PR News at http://Beneficience.com

MEDIA REQUESTS + MEDIA BOOKING: Dr. Burd is available for relevant events, speaking engagements, radio, podcast, television and media opportunities, news interviews, et als. Burd's media contact information is available now by request online at Beneficience.com Legacy PR at https://beneficience.com/?s=Dr.+John+Burd

Contact
Dr. Tracey Bond, MPRL
Certified Publicist of Record
for John Burd, PhD
***@beneficience.com


Source: Beneficience.com Legacy PR
Filed Under: Business, Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • ToneWell Launches AI Wellness Platform with 30-Second Voice-Based Performance Readiness Scan™
  • Lokal Media House Achieves Yelp Platinum Partner Status
  • World's First AI-Native Industrial Facility is Under Construction by Carbon AMS with rhobot.ai
  • VIP Vacations Wins Diamon Status with AIC Hotel Group
  • $57 Billion U.S. Marine Industry Presents Major Growth Opportunity for Newly Public Off The Hook Yacht Sales, Inc. (N Y S E: OTH)
  • Deimler Chiropractic Announces Expansion
  • Dr. Alexander Eastman Returns to Suburban Hospital to Deliver Keynote on Crisis Leadership
  • Scoop Social Co.'s Mobile Dessert Truck Business Offer A Lifestyle Of Flavor, Fun, and Freedom
  • Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
  • Lakefront Acreage in Longwood's Ravensbrook Community Hits the Market
  • Monika Balayan Elected Fellow of the Royal Society of Arts (FRSA)
  • Best Companies Group Launches Best Companies to Work for in New York Program
  • We're Winning: Historic Plunge in Overdose Deaths Marks Stunning Reversal in America's Drug Crisis
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • IDI Consulting Spreads Holiday Cheer to Families in Need with 11th Annual Toys for Tots Drive
  • Escajeda Masonry & Concrete Among Pittsburgh's Fastest-Growing Companies
  • New 2025–2026 Energy Rebates: Squeaks Services Explains How to Qualify
  • CCHR's New Documentary Prescription for Violence Highlights Overlooked Safety Warnings
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership
  • Men's Health Network Announces a New Feature to Support the Well-Being of Men When and Where They Are through Text Alerts

Popular on PennZone

  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 135
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 119
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • New Free Science Bingo Cards Help Grade 1 Students Learn Through Play
  • Revenue Optics Ignites AI Revolution in Industrial Distribution
  • Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
  • Passion Struck Network Debuts: A Creator-First Platform for Purpose-Driven Podcasting and Human Impact
  • HR Soul Consulting Recognized as a 2025 Inc. Power Partner Award Winner for the Fourth Consecutive Year
  • Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia

Similar on PennZone

  • Smile! Dental Center Named 2025 "Best Dentist" in North Pittsburgh, Celebrating High-Tech Care and Heartfelt Service
  • Dr. Johnny Shanks, As Seen on TV, Announces 20% Off Dental Implant Treatments | Tennessee's Leading All-on-X Provider
  • Star Sleep & Wellness Expands to Pearland, Texas — Bringing Life-Changing Sleep Care to More Communities
  • Fort Lauderdale Dentist Dr. Taskonak & IN A DAY SMILE Receive Emmy Nomination for Life-Changing Documentary "The Weight of a Smile"
  • Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
  • BET and Soul Train Awards - GONE! - Introducing The World Hip Hop Awards
  • AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)
  • Americans Are Building Family Legacies That Last Generations — Not Just Paychecks That Last a Month
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us